Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Peptic Ulcer

Free Subscription Articles published in Gut Retrieve available abstracts of 52 articles: HTML format

Single Articles

November 2023
1. LUO S, Ru J, Khan Mirzaei M, Xue J, et al
   Helicobacter pylori infection alters gut virome by expanding temperate phages linked to increased risk of colorectal cancer.
   Gut. 2023 Nov 2:gutjnl-2023-330362. doi: 10.1136/gutjnl-2023-330362.
   PubMed    
   
   
   September 2023
2. LIU BD, Udemba SC, Liang K, Tarabichi Y, et al
   Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort st
   Gut. 2023 Sep 22:gutjnl-2023-329651. doi: 10.1136/gutjnl-2023-329651.
   PubMed     Abstract available
   
   
   July 2023
3. 
   Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
   Gut. 2023 Jul 19:gutjnl-2022-329259. doi: 10.1136/gutjnl-2022-329259.
   PubMed     Abstract available
   
   
   June 2023
4. SJOMINA O, Vangravs R, Leonova E, Polaka I, et al
   Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut.
   Gut. 2023 Jun 26:gutjnl-2023-329792. doi: 10.1136/gutjnl-2023-329792.
   PubMed    
   
   
   May 2023
5. ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al
   Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
   Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052.
   PubMed    
   
   
   
6. LEI WY, Lee JY, Chuang SL, Bair MJ, et al
   Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
   Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871.
   PubMed     Abstract available
   
   
   April 2023
7. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
   Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
   Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
   PubMed     Abstract available
   
   
   
8. YE BD
   Proton pump inhibitors and the risk of inflammatory bowel disease: cause, protopathic bias or others?
   Gut. 2023 Apr 4:gutjnl-2023-329506. doi: 10.1136/gutjnl-2023-329506.
   PubMed    
   
   
   March 2023
9. CHEN PY, Tsai FP, Chen MJ, Yang HY, et al
   Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials.
   Gut. 2023 Mar 31:gutjnl-2023-329826. doi: 10.1136/gutjnl-2023-329826.
   PubMed    
   
   
   
10. ZHANG J, Deng Y, Liu C, Wang H, et al
    'Family-based' strategy for Helicobacter pylori infection screening: an efficient alternative to 'test and treat' strategy.
    Gut. 2023 Mar 7:gutjnl-2023-329696. doi: 10.1136/gutjnl-2023-329696.
    PubMed    
    
    
    
11. MALFERTHEINER P, Megraud F, Rokkas T, Gisbert JP, et al
    Empiric use of standard triple therapy in Helicobacter pylori eradication does not require readjustment in the clarithromycin resistance cut-off point.
    Gut. 2023 Mar 6:gutjnl-2023-329712. doi: 10.1136/gutjnl-2023-329712.
    PubMed    
    
    
    January 2023
12. ABRAHAMI D, Pradhan R, Yin H, Yanofsky R, et al
    Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study.
    Gut. 2023 Jan 30:gutjnl-2022-328866. doi: 10.1136/gutjnl-2022-328866.
    PubMed     Abstract available
    
    
    
13. MEIER B, Schmidt A, Caca K
    Over-the-scope clips versus standard therapy in upper gastrointestinal bleeding.
    Gut. 2023 Jan 27:gutjnl-2022-329296. doi: 10.1136/gutjnl-2022-329296.
    PubMed    
    
    
    
14. ZHOU XZ, Lyu NH, Zhu HY, Cai QC, et al
    Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention.
    Gut. 2023 Jan 23:gutjnl-2022-328965. doi: 10.1136/gutjnl-2022-328965.
    PubMed     Abstract available
    
    
    December 2022
15. HSU PI, Chuah SK, Yamaoka Y, Wu DC, et al
    Cut-off value of clarithromycin resistance in the treatment of Helicobacter pylori infection: how low is low?
    Gut. 2022 Dec 30:gutjnl-2022-329253. doi: 10.1136/gutjnl-2022-329253.
    PubMed    
    
    
    
16. BURGOS-SANTAMARIA D, Nyssen OP, Gasbarrini A, Vaira D, et al
    Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg).
    Gut. 2022 Dec 5:gutjnl-2022-328232. doi: 10.1136/gutjnl-2022-328232.
    PubMed     Abstract available
    
    
    November 2022
17. BORNSCHEIN J, Pritchard DM, Malfertheiner P
    Letter to the editor: Helicobacter pylori eradication - the proof is not in the symptoms.
    Gut. 2022 Nov 15. pii: gutjnl-2022-329057. doi: 10.1136/gutjnl-2022-329057.
    PubMed    
    
    
    October 2022
18. CHAN S, Pittayanon R, Wang HP, Chen JH, et al
    Use of over-the-scope clip (OTSC) versus standard therapy for the prevention of rebleeding in large peptic ulcers (size >/=1.5 cm): an open-labelled, multicentre international randomised controlled trial.
    Gut. 2022 Oct 28. pii: gutjnl-2022-327007. doi: 10.1136/gutjnl-2022-327007.
    PubMed     Abstract available
    
    
    August 2022
19. MALFERTHEINER P, Megraud F, Rokkas T, Gisbert JP, et al
    Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report.
    Gut. 2022 Aug 8. pii: gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745.
    PubMed     Abstract available
    
    
    June 2022
20. RUGGE M, Bricca L, Guzzinati S, Sacchi D, et al
    Autoimmune gastritis: long-term natural history in naive Helicobacter pylori-negative patients.
    Gut. 2022 Jun 30. pii: gutjnl-2022-327827. doi: 10.1136/gutjnl-2022-327827.
    PubMed     Abstract available
    
    
    April 2022
21. KALAPALA R, Karyampudi A, Nabi Z, Darisetty S, et al
    Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial.
    Gut. 2022;71:686-694.
    PubMed     Abstract available
    
    
    March 2022
22. MEIER B, Wannhoff A, Denzer U, Stathopoulos P, et al
    Over-the-scope-clips versus standard treatment in high-risk patients with acute non-variceal upper gastrointestinal bleeding: a randomised controlled trial (STING-2).
    Gut. 2022 Mar 23. pii: gutjnl-2021-325300. doi: 10.1136/gutjnl-2021-325300.
    PubMed     Abstract available
    
    
    January 2022
23. FORD AC, Tsipotis E, Yuan Y, Leontiadis GI, et al
    Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis.
    Gut. 2022 Jan 12. pii: gutjnl-2021-326583. doi: 10.1136/gutjnl-2021-326583.
    PubMed     Abstract available
    
    
    December 2021
24. DONG C, Lee YH, Tan TY, Yao CC, et al
    Correspondence to proton pump inhibitors and risk of colorectal cancer.
    Gut. 2021 Dec 2. pii: gutjnl-2021-326139. doi: 10.1136/gutjnl-2021-326139.
    PubMed    
    
    
    
25. ABRAHAMI D, Azoulay L
    Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'.
    Gut. 2021 Dec 2. pii: gutjnl-2021-326544. doi: 10.1136/gutjnl-2021-326544.
    PubMed    
    
    
    
26. ZERBIB F
    Diagnosis of GORD: is the 'grey area' expanding?
    Gut. 2021;70:2221-2222.
    PubMed    
    
    
    
27. RUSU RI, Fox MR, Tucker E, Zeki S, et al
    Validation of the Lyon classification for GORD diagnosis: acid exposure time assessed by prolonged wireless pH monitoring in healthy controls and patients with erosive oesophagitis.
    Gut. 2021;70:2230-2237.
    PubMed     Abstract available
    
    
    November 2021
28. ZENG R, Sha W, Wang J, Zhuo Z, et al
    Evaluation of proton pump inhibitors and risks of gastric cancer.
    Gut. 2021 Nov 26. pii: gutjnl-2021-326291. doi: 10.1136/gutjnl-2021-326291.
    PubMed    
    
    
    
29. DING SZ, Du YQ, Lu H, Wang WH, et al
    Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition).
    Gut. 2021 Nov 26. pii: gutjnl-2021-325630. doi: 10.1136/gutjnl-2021-325630.
    PubMed     Abstract available
    
    
    
30. LOOSEN SH, Kostev K, Luedde M, Qvartskhava N, et al
    Long-term use of proton pump inhibitors (PPIs) is associated with an increased risk of type 2 diabetes.
    Gut. 2021 Nov 1. pii: gutjnl-2021-326297. doi: 10.1136/gutjnl-2021-326297.
    PubMed    
    
    
    October 2021
31. SHAH S, Halvorson A, McBay B, Dorn C, et al
    Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohort.
    Gut. 2021 Oct 18. pii: gutjnl-2021-325701. doi: 10.1136/gutjnl-2021-325701.
    PubMed    
    
    
    September 2021
32. GUO CLT, Wong SH, Lau LHS, Lui RNS, et al
    Timing of endoscopy for acute upper gastrointestinal bleeding: a territory-wide cohort study.
    Gut. 2021 Sep 21. pii: gutjnl-2020-323054. doi: 10.1136/gutjnl-2020-323054.
    PubMed     Abstract available
    
    
    August 2021
33. ARAI J, Niikura R, Hayakawa Y, Aoki T, et al
    OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.
    Gut. 2021 Aug 3. pii: gutjnl-2021-325551. doi: 10.1136/gutjnl-2021-325551.
    PubMed    
    
    
    July 2021
34. PATEL J, Berezowski I, Janapala RN, Pourmand A, et al
    Proton pump inhibitors and gastric cancer: a population-based cohort study.
    Gut. 2021 Jul 14. pii: gutjnl-2021-325385. doi: 10.1136/gutjnl-2021-325385.
    PubMed    
    
    
    
35. OSTER P, Vaillant L, Riva E, McMillan B, et al
    Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
    Gut. 2021 Jul 12. pii: gutjnl-2020-323392. doi: 10.1136/gutjnl-2020-323392.
    PubMed     Abstract available
    
    
    
36. ABRAHAMI D, McDonald EG, Schnitzer ME, Barkun AN, et al
    Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
    Gut. 2021 Jul 5. pii: gutjnl-2021-325097. doi: 10.1136/gutjnl-2021-325097.
    PubMed     Abstract available
    
    
    
37. ABRAHAMI D, McDonald EG, Schnitzer ME, Barkun AN, et al
    Proton pump inhibitors and risk of colorectal cancer.
    Gut. 2021 Jul 1. pii: gutjnl-2021-325096. doi: 10.1136/gutjnl-2021-325096.
    PubMed     Abstract available
    
    
    June 2021
38. ONG JS, An J, Han X, Law MH, et al
    Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis.
    Gut. 2021 Jun 29. pii: gutjnl-2020-323906. doi: 10.1136/gutjnl-2020-323906.
    PubMed     Abstract available
    
    
    May 2021
39. SEO SI, Park CH, You SC, Kim JY, et al
    Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
    Gut. 2021 May 11. pii: gutjnl-2020-323845. doi: 10.1136/gutjnl-2020-323845.
    PubMed     Abstract available
    
    
    April 2021
40. MEGRAUD F, Bruyndonckx R, Coenen S, Wittkop L, et al
    Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community.
    Gut. 2021 Apr 9. pii: gutjnl-2021-324032. doi: 10.1136/gutjnl-2021-324032.
    PubMed     Abstract available
    
    
    
41. NIENHUSER H, Kim W, Malagola E, Ruan T, et al
    Mist1+ gastric isthmus stem cells are regulated by Wnt5a and expand in response to injury and inflammation in mice.
    Gut. 2021;70:654-665.
    PubMed     Abstract available
    
    
    March 2021
42. SUNG JJY, Laine L, Kuipers EJ, Barkun AN, et al
    Towards personalised management for non-variceal upper gastrointestinal bleeding.
    Gut. 2021 Mar 1. pii: gutjnl-2020-323846. doi: 10.1136/gutjnl-2020-323846.
    PubMed     Abstract available
    
    
    December 2020
43. SPILLER RC, Jalanka J
    Brachyspira and IBS with diarrhoea: a Helicobacter pylori moment?
    Gut. 2020 Dec 24. pii: gutjnl-2020-323370. doi: 10.1136/gutjnl-2020-323370.
    PubMed    
    
    
    
44. HE Q, Yang M, Qin X, Fan D, et al
    Risk stratification for proton pump inhibitor-associated type 2 diabetes: a population-based cohort study.
    Gut. 2020 Dec 22. pii: gutjnl-2020-323816. doi: 10.1136/gutjnl-2020-323816.
    PubMed    
    
    
    
45. LU TX, Dapas M, Lin E, Peters T, et al
    The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies.
    Gut. 2020 Dec 17. pii: gutjnl-2020-321609. doi: 10.1136/gutjnl-2020-321609.
    PubMed     Abstract available
    
    
    
46. LEE SW, Yang JM, Yoo IK, Moon SY, et al
    Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort.
    Gut. 2020 Dec 10. pii: gutjnl-2020-323672. doi: 10.1136/gutjnl-2020-323672.
    PubMed    
    
    
    
47. ZHOU J, Wang X, Lee S, Wu WKK, et al
    Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study.
    Gut. 2020 Dec 4. pii: gutjnl-2020-323668. doi: 10.1136/gutjnl-2020-323668.
    PubMed    
    
    
    November 2020
48. LI GF, An XX, Yu Y, Jiao LR, et al
    Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis.
    Gut. 2020 Nov 10. pii: gutjnl-2020-323366. doi: 10.1136/gutjnl-2020-323366.
    PubMed    
    
    
    October 2020
49. LIOU JM, Malfertheiner P, Lee YC, Sheu BS, et al
    Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.
    Gut. 2020 Oct 1. pii: gutjnl-2020-322368. doi: 10.1136/gutjnl-2020-322368.
    PubMed     Abstract available
    
    
    September 2020
50. ZHOU X, Zhu H, Chen Y, Li Z, et al
    Role of Helicobacter pylori in gastric diseases pathogenesis cannot be ignored.
    Gut. 2020 Sep 29. pii: gutjnl-2020-322629. doi: 10.1136/gutjnl-2020-322629.
    PubMed    
    
    
    
51. YUAN J, He Q, Nguyen LH, Wong MCS, et al
    Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.
    Gut. 2020 Sep 28. pii: gutjnl-2020-322557. doi: 10.1136/gutjnl-2020-322557.
    PubMed     Abstract available
    
    
    April 2020
52. WONG GLH, Lau LHS, Ching JYL, Tse YK, et al
    Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial.
    Gut. 2020;69:652-657.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Peptic Ulcer is free of charge.